⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8439976 | 1.00 | CYP19A1 (0.37) | — | |
| Hydrochloric Acid SCHEMBL7401834 | 1.00 | CYP19A1 (0.37) | — | |
| SCHEMBL3488529 | 0.84 | KDM2B (0.39) | — | |
| SCHEMBL14254669 | 0.84 | KDM2B (0.39) | — | |
| Hydrochloric Acid SCHEMBL1994942 | 0.84 | KDM2B (0.39) | — | |
| SCHEMBL8440410 | 0.84 | KDM2B (0.39) | — | |
| Hydrochloric Acid SCHEMBL30232427 | 0.84 | KDM2B (0.39) | — | |
| SCHEMBL2675534 | 0.81 | HTR6 (0.35) | — | |
| SCHEMBL1993621 | 0.78 | MEN1 (0.38) | — | |
| Hydrochloric Acid SCHEMBL3862147 | 0.78 | MEN1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116829151-A | Azaquinazoline pan KRAS inhibitors | 米拉蒂治疗股份有限公司 | 2023-09-29 | — | — | CN | disclosed |
| WO-2023018812-A1 | HETEROCYCLIC COMPOUNDS AND METHODS OF USE | AMGEN INC. (US) | 2023-02-16 | — | — | WO | disclosed |
| EP-2305640-A2 | Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases | AstraZeneca AB (SE) | 2011-04-06 | — | — | EP | disclosed |
| US-20080293775-A1 | Substituted Diphenylethers, -Amines, -Sulfides and -Methanes for the Treatment of Respiratory Disease | ASTRAZENECA AB (SE) | 2008-11-27 | — | — | US | disclosed |
| EP-1963259-A2 | SUBSTITUTED DIPHENYLETHERS, -AMINES, -SULFIDES AND -METHANES FOR THE TREATMENT OF RESPIRATORY DISEASE | AstraZeneca AB (SE) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007068894-A2 | SUBSTITUTED DIPHENYLETHERS, -AMINES, -SULFIDES AND -METHANES FOR THE TREATMENT OF RESPIRATORY DISEASE | ASTRAZENECA AB (SE) | 2007-06-21 | — | — | WO | disclosed |
| CN-1285588-C | Farnesyl protein transferase inhibitors | SCHERING CORP (US) | 2006-11-22 | — | — | CN | disclosed |
| CN-1352642-A | Farnesyl protein transferase inhibitors | SCHERING CORP (US) | 2002-06-05 | — | — | CN | disclosed |
| US-6362188-B1 | ANTICANCER AGENTS | SCHERING CORPORATION | 2002-03-26 | — | — | US | disclosed |